Metolactone 2.5 Mg/50 Mg Tablet

Metolactone 2.5 Mg/50 Mg Tablet is an known as a quinazoline diuretic which has actions that are quite similar to thiazide diuretics. The mechanism of its action is to stimulate the kidneys to drain out certain chemicals, which eventually helps to drain a heavy quantity of water from the kidneys. The main purpose of this drug is to lower high blood pressure. Depending on your medical history, the doctor may also administer the medicine for treating other health issues. It may also be administered with a combination of other drugs. The drug may increase your urge to urinate frequently.

Metolactone 2.5 Mg/50 Mg Tablet is contraindicated in patients who have difficulty in urination, if you are allergic to the drug or if you are in a comatose state caused by a liver disorder or organ failure. Precaution must be maintained when administering the dosage to pregnant women or breastfeeding women. The effects on foetus or infants are yet not known, therefore the doctor’s discretion after a thorough diagnosis of the patient’s condition. You should definitely inform the doctor if you are allergic to any substance, food or drugs. You should also take necessary precautions if you have suffered from fluctuating levels of electrolytes in your blood or gout.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a General Uro before using this medicine.

• Hypertension

• Heart Failure

• Cirrhosis

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a General Uro before using this medicine.

• Nausea

• Vomiting

• Leg Cramps

• Dizziness

• Drowsiness

• Confusion

• Breast Enlargement In Male

• Increased Creatinine Level In Blood

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a General Uro before using this medicine.

• Is It safe with alcohol?

  Taking Metolazone with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
  Spironolactone and alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.

• Are there any pregnancy warnings?

  Metolactone 2.5 mg/50 mg tablet may be unsafe to use during pregnancy.
  Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.

• Are there any breast-feeding warnings?

  Metolactone 2.5 mg/50 mg tablet is probably safe to use during breastfeeding. Please consult your doctor.

• Is it safe to drive while on this medicine?

  Caution is advised when driving or operating machinery.
  Caution is advised when driving or operating machinery until the response to initial treatment has been determined.

• Does this affect kidney function?

  Caution should be used in patients with impaired renal function.
  Care should be taken with severe hepatic and renal impairment.

• Does this affect liver function?

  There is no data available. Please consult doctor before consuming the drug.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a General Uro before using this medicine.

This medication mainly works by blocking the reuptake of sodium at the cortical diluting site and proximal convoluted tubule. This results in increased excretion of potassium through the urine.

Information given here is based on the salt content of the medicine. Uses and effects of the medicine may vary from person to person. It is advisable to consult a General Uro before using this medicine.